Beam Therapeutics Inc 10-Q for FY2022 Q2
Beam Therapeutics Inc. (BEAM)
10-Q
2022-08-09
For: 2022-06-30
View Original
Added on
April 09, 2026
About this 10-Q
Beam Therapeutics Inc filed this 10-Q on August 9, 2022, covering the quarter ended June 30, 2022 (FY2022 Q2).
Headline figures
Quarter ended June 30, 2022, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $16.65M
- up 277433.3% from $6000 a year earlier
- Net loss
- $71.95M
- compared with a net loss of $76.25M a year earlier
- Diluted EPS
- -$1.02
- compared with -$1.23 a year earlier